USA: A recent post hoc analysis of the ORAL Surveillance trial has highlighted the essential role of statins in mitigating major adverse cardiovascular events (MACE) among patients with rheumatoid ...

Combination therapy with a statin plus an intestinal agent can be used in individuals that can only tolerate a low-dose statin or an intermittent dosing of the statin. The combination of a statin ...

Clinicians are advised to determine which of their patients’ chronic medications are really needed to improve outcomes.

Among participants in the landmark ORAL Surveillance study assigned to the JAK inhibitor tofacitinib (Xeljanz) and also using ...

ANSWER: Because all drugs have the potential for harm, it’s always good to take a clear-eyed look at the risks and benefits ...

In the trial, 20% of patients didn’t respond well to the PCSK9 inhibitor—could genetic markers be used to tailor therapy?

S.A. ANSWER: Lovastatin (Mevacor) was the first statin drug approved, but newer statin drugs are more potent and have less likelihood of side effects. So, I don’t have a single patient on ...

My physician is not concerned, but I am. Why isn’t lovastatin bringing down my cholesterol levels to normal? — S.A. ANSWER: Lovastatin (Mevacor) was the first statin drug approved, but newer statin ...

While statins can reduce LDL levels and ASCVD events, high Lp(a) poses an independent risk that will need attention, too.

The Statistical Institute of Jamaica (STATIN) is reporting that the rate of inflation or the average rate of increases in ...

A study was conducted to determine the association between housing unaffordability and health outcomes and medication ...